Venous thromboembolic events in the rehabilitation setting

PM and R

Volumn 2, Issue 7, 2010, Pages 647-663

  Kelly, Brian M ^a   Yoder, Brian M ^b   Tang, Chi Tsai ^c   Wakefield, Thomas W ^d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b REHABILITATION INSTITUTE OF MICHIGAN   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; D DIMER; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

AMPUTATION; ANTICOAGULATION; ARTICLE; BRAIN INJURY; BURN; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CLINICAL PROTOCOL; CRANIOTOMY; DEEP VEIN THROMBOSIS; EMERGENCY CARE; HIP SURGERY; HUMAN; INJURY; KNEE SURGERY; LUNG EMBOLISM; MOBILIZATION; MORBIDITY; MORTALITY; NEOPLASM; ORTHOSIS; PATIENT ASSESSMENT; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; RADIOCARDIOGRAPHY; REHABILITATION; SPINAL CORD INJURY; SPINE SURGERY; SYMPTOM; THROMBOSIS; TRAUMATIC BRAIN INJURY; TREATMENT DURATION; ULTRASOUND; VENOUS THROMBOEMBOLISM; DISABLED PERSON; ENZYME LINKED IMMUNOSORBENT ASSAY; MULTIPLE TRAUMA; ORTHOPEDIC SURGERY; ORTHOTICS; PHYSICAL MEDICINE; POSTOPERATIVE COMPLICATION; REVIEW; RISK FACTOR; STROKE; VEIN THROMBOSIS;

AMPUTEES; BRAIN INJURIES; BURNS; CRANIOTOMY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MULTIPLE TRAUMA; NEOPLASMS; ORTHOPEDIC PROCEDURES; ORTHOTIC DEVICES; PHYSICAL MEDICINE; POSTOPERATIVE COMPLICATIONS; PULMONARY EMBOLISM; RISK FACTORS; SPINAL CORD INJURIES; STROKE; VENOUS THROMBOSIS; WOUNDS AND INJURIES;

EID: 77958148278     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2010.03.029     Document Type: Article

References (211)

1. Siegler EL, Stineman MG, Maislin G. Development of complications during rehabilitation. Arch Intern Med 1994;154:2185-2190.
2. Chen D, Apple DF Jr, Hudson LM, Bode R. Medical complications during acute rehabilitation following spinal cord injury-current experience of the Model Systems. Arch Phys Med Rehabil 1999;80:1397-1401.
3. Burke B, Kumar R, Vickers V, Grant E, Scremin E. Deep vein thrombosis after lower limb amputation. Am J Phys Med Rehabil 2000;79:145-149.
4. Roth EJ, Lovell L, Harvey RL, Heinemann AW, Semik P, Diaz S. Incidence of and risk factors for medical complications during stroke rehabilitation. Stroke 2001;32:523-529.
5. Carney ML, Ullrich P, Esselman P. Early unplanned transfers from inpatient rehabilitation. Am J Phys Med Rehabil 2006;85:453-460; quiz 461-453.
6. Shorr AF. The pharmacoeconomics of deep vein thrombosis treatment. Am J Med 2007;120(10 Suppl 2):S35-S41.
7. de Lissovoy G. Economic issues in the treatment and prevention of deep vein thrombosis from a managed care perspective. Am J Manage Care 2001;7(17 Suppl):S535-538; discussion S538-544.
8. Merkel A. Origin and natural history of deep vein thrombosis of the legs. Sem Vasc Med 2005;5:10.
9. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Risk factors for deep vein thrombosis and pulmonary embolism: A population-based case-control study. Arch Intern Med 2000;160:809-815.
10. Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005;293:715-722.
11. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991;151:933-938.
12. Motykie GD, Zebala LP, Caprini JA, et al. A guide to venous thromboembolism risk factor assessment. J Thromb Thrombolysis 2000;9:253-262.
13. White RH, Zhou H, Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost 2003;90:446-455.
14. Ageno W, Squizzato A, Garcia D, Imberti D. Epidemiology and risk factors of venous thromboembolism. Semin Thromb Hemost 2006;32:651-658.
15. Agnelli G, Becattini C. Treatment of DVT: How long is enough and how do you predict recurrence. J Thromb Thrombolysis 2008;25:37-44.
16. Hull RD, Hirsh J, Carter CJ, et al. Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Intern Med 1983;98:891-899.
17. Rollins DL, Semrow CM, Friedell ML, Lloyd WE, Buchbinder D. Origin of deep vein thrombi in an ambulatory population. Am J Surg 1988;156:122-125.
18. Meignan M, Rosso J, Gauthier H, et al. Systematic lung scans reveal a high frequency of silent pulmonary embolism in patients with proximal deep venous thrombosis. Arch Intern Med 2000;160:159-164.
19. Kearon C. Natural history of venous thromboembolism. Circulation 2003;107(23 Suppl 1):I22-I30.
20. Markel A. Origin and natural history of deep vein thrombosis of the legs. Semin Vasc Med 2005;5:65-74.
21. Lagerstedt CI, Olsson CG, Fagher BO, Oqvist BW, Albrechtsson U. Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet 1985;2:515-518.
22. Schulman S, Rhedin AS, Lindmarker P, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med 1995;332:1661-1665.
23. Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996;125:1-7.
24. Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 1998;338:409-415.
25. Hansson PO, Sorbo J, Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis: Incidence and risk factors. Arch Intern Med 27 2000;160:769-774.
26. Cushman M, Glynn RJ, Goldhaber SZ, et al. Hormonal factors and risk of recurrent venous thrombosis: The prevention of recurrent venous thromboembolism trial. J Thromb Haemost 2006;4:2199-2203.
27. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Predictors of survival after deep vein thrombosis and pulmonary embolism: A population-based, cohort study. Arch Intern Med 1999;159:445-453.
28. Heit JA, Mohr DN, Silverstein MD, Petterson TM, O'Fallon WM, Melton LJ 3rd. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: A population-based cohort study. Arch Intern Med 2000;160:761-768.
29. Kommareddy A, Zaroukian MH, Hassouna HI. Upper extremity deep venous thrombosis. Semin Thromb Hemost 2002;28:89-99.
30. Arnhjort T, Persson LM, Rosfors S, Ludwigs U, Larfars G. Primary deep vein thrombosis in the upper limb: A retrospective study with emphasis on pathogenesis and late sequelae. Eur J Intern Med 2007;18:304-308.
31. Mason RJ, Murray JF, Broaddus BC, et al eds. Murray & Nadel's Textbook of Respiratory Medicine. 4th ed. Philadelphia: Saunders; 2005.
32. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th edition). Chest 2008;133(6 Suppl):381S-453S.
33. Prandoni P, Bernardi E, Marchiori A, et al. The long term clinical course of acute deep vein thrombosis of the arm: prospective cohort study. BMJ 2004;329:484-485.
34. Brandjes DP, Buller HR, Heijboer H, et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997;349:759-762.
35. Mohr DN, Silverstein MD, Heit JA, Petterson TM, O'Fallon WM, Melton LJ. The venous stasis syndrome after deep venous thrombosis or pulmonary embolism: A population-based study. Mayo Clin Proc 2000;75:1249-1256.
36. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. 8th ed. Chest 2008;133(6 Suppl):454S-545S.
37. Kahn SR, Elman EA, Bornais C, Blostein M, Wells PS. Post-thrombotic syndrome, functional disability and quality of life after upper extremity deep venous thrombosis in adults. Thromb Haemost 2005;93:499-502.
38. Kahn SR, Ginsberg JS. Relationship between deep venous thrombosis and the postthrombotic syndrome. Arch Intern Med 2004;164:17-26.
39. Ashrani AA, Heit JA. Incidence and cost burden of post-thrombotic syndrome. J Thromb Thrombolysis 2009;28:465-476.
40. Kolbach DN, Sandbrink MW, Hamulyak K, Neumann HA, Prins MH. Non-pharmaceutical measures for prevention of post-thrombotic syndrome. Cochrane Database Syst Rev 2004;(1):CD004174.
41. Ginsberg JS, Magier D, Mackinnon B, Gent M, Hirsh J. Intermittent compression units for severe post-phlebitic syndrome: A randomized crossover study. CMAJ 1999;160:1303-1306.
42. Trujillo-Santos J, Perea-Milla E, Jimenez-Puente A, et al. Bed rest or ambulation in the initial treatment of patients with acute deep vein thrombosis or pulmonary embolism: Findings from the RIETE registry. Chest 2005;127:1631-1636.
43. Wells PS, Owen C, Doucette S, Fergusson D, Tran H. Does this patient have deep vein thrombosis? JAMA 2006;295:199-207.
44. Anand SS, Wells PS, Hunt D, Brill-Edwards P, Cook D, Ginsberg JS. Does this patient have deep vein thrombosis? JAMA 1998;279:1094-1099.
45. Righini M, Goehring C, Bounameaux H, Perrier A. Effects of age on the performance of common diagnostic tests for pulmonary embolism. Am J Med 2000;109:357-361.
46. Bosson JL, Barro C, Satger B, Carpentier PH, Polack B, Pernod G. Quantitative high D-dimer value is predictive of pulmonary embolism occurrence independently of clinical score in a well-defined low risk factor population. J Thromb Haemost 2005;3:93-99.
47. Bosson JL, Labarere J, Sevestre MA, et al. Deep vein thrombosis in elderly patients hospitalized in subacute care facilities: A multicenter cross-sectional study of risk factors, prophylaxis, and prevalence. Arch Intern Med 2003;163:2613-2618.
48. Imberti D. D-dimer testing: Advantages and limitations in emergency medicine for managing acute venous thromboembolism. Intern Emerg Med 2007;2:70-71.
49. Heim SW, Schectman JM, Siadaty MS, Philbrick JT. D-dimer testing for deep venous thrombosis: A metaanalysis. Clin Chem 2004;50:1136-1147.
50. Janssen MC, Wollersheim H, Verbruggen B, Novakova IR. Rapid D-dimer assays to exclude deep venous thrombosis and pulmonary embolism: Current status and new developments. Semin Thromb Hemost 1998;24:393-400.
51. Janssen MC, Heebels AE, de Metz M, et al. Reliability of five rapid D-dimer assays compared to ELISA in the exclusion of deep venous thrombosis. Thromb Haemost 1997;77:262-266.
52. Wells PS, Anderson DR, Rodger M, et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 2003;349:1227-1235.
53. Akman MN, Cetin N, Bayramoglu M, Isiklar I, Kilinc S. Value of the D-dimer test in diagnosing deep vein thrombosis in rehabilitation inpatients. Arch Phys Med Rehabil 2004;85:1091-1094.
54. Birdwell B. Recent clinical trials in the diagnosis of deep-vein thrombosis. Curr Opin Hematol 1999;6:275-279.
55. Tan M, van Rooden CJ, Westerbeek RE, Huisman MV. Diagnostic management of clinically suspected acute deep vein thrombosis. Br J Haematol 2009;146:347-360.
56. Streiff MB. Diagnosis and initial treatment of venous thromboembolism in patients with cancer. J Clin Oncol 2009;27:4889-4894.
57. Goodacre S, Sampson F, Stevenson M, et al. Measurement of the clinical and cost-effectiveness of non-invasive diagnostic testing strategies for deep vein thrombosis. Health Technol Assess 2006;10:1-168, iii-iv.
58. Michiels JJ, Gadisseur A, Van Der Planken M, et al. A critical appraisal of non-invasive diagnosis and exclusion of deep vein thrombosis and pulmonary embolism in outpatients with suspected deep vein thrombosis or pulmonary embolism: How many tests do we need? Int Angiol 2005;24:27-39.
59. Wells PS, Anderson DR. Modern approach to diagnosis in patients with suspected deep vein thrombosis. Haemostasis 1999;29(Suppl S1):10-20.
60. Wells PS, Anderson DR, Ginsberg J. Assessment of deep vein thrombosis or pulmonary embolism by the combined use of clinical model and noninvasive diagnostic tests. Semin Thromb Hemost 2000;26:643-656.
61. Wells PS. Advances in the diagnosis of venous thromboembolism. J Thromb Thrombolysis. 2006;21:31-40.
62. Wells PS, Ginsberg JS, Anderson DR, et al. Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med 1998;129:997-1005.
63. Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: Increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000;83:416-420.
64. Mayo JR, Remy-Jardin M, Muller NL, et al. Pulmonary embolism: Prospective comparison of spiral CT with ventilation-perfusion scintigraphy. Radiology 1997;205:447-452.
65. Stein PD, Fowler SE, Goodman LR, et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med. Jun 1 2006;354(22):2317-2327.
66. Rodger MA, Carrier M, Jones GN, et al. Diagnostic value of arterial blood gas measurement in suspected pulmonary embolism. Am J Respir Crit Care Med 2000;162:2105-2108.
67. Stein PD, Woodard PK, Weg JG, et al. Diagnostic pathways in acute pulmonary embolism: Recommendations of the PIOPED II Investigators. Radiology 2007;242:15-21.
68. Kadyan V, Clinchot DM, Colachis SC. Cost-effectiveness of duplex ultrasound surveillance in spinal cord injury. Am J Phys Med Rehabil 2004;83:191-197.
69. Merli GJ, Herbison GJ, Ditunno JF, et al. Deep vein thrombosis: Prophylaxis in acute spinal cord injured patients. Arch Phys Med Rehabil 1988;69:661-664.
70. Myllynen P, Kammonen M, Rokkanen P, Bostman O, Lalla M, Laasonen E. Deep venous thrombosis and pulmonary embolism in patients with acute spinal cord injury: A comparison with nonparalyzed patients immobilized due to spinal fractures. J Trauma 1985;25:541-543.
71. Seifert J, Lob G, Stoephasius E, Probst J, Brendel W. Blood flow in muscles of paraplegic patients under various conditions measured by a double isotope technique. Paraplegia 1972;10:185-191.
72. Rossi EC, Green D, Rosen JS, Spies SM, Jao JS. Sequential changes in factor VIII and platelets preceding deep vein thrombosis in patients with spinal cord injury. Br J Haematol 1980;45:143-151.
73. Winther K, Gleerup G, Snorrason K, Biering-Sorensen F. Platelet function and fibrinolytic activity in cervical spinal cord injured patients. Thromb Res 1992;65:469-474.
74. Ersoz G, Ficicilar H, Pasin M, Yorgancioglu R, Yavuzer S. Platelet aggregation in traumatic spinal cord injury. Spinal Cord 1999;37:644-647.
75. Sipski ML, Richards JS. Spinal cord injury rehabilitation: State of the science. Am J Phys Med Rehabil 2006;85:310-342.
76. Jones T, Ugalde V, Franks P, Zhou H, White RH. Venous thromboembolism after spinal cord injury: Incidence, time course, and associated risk factors in 16,240 adults and children. Arch Phys Med Rehabil 2005;86:2240-2247.
77. Geerts WH, Jay RM, Code KI, et al. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 1996;335:701-707.
78. Prevention of venous thromboembolism in the rehabilitation phase after spinal cord injury: Prophylaxis with low-dose heparin or enoxaparin. J Trauma 2003;54:1111-1115.
79. Prevention of thromboembolism in spinal cord injury. Consortium for Spinal Cord Medicine. J Spinal Cord Med 1997;20:259-283.
80. Prevention of venous thromboembolism in the acute treatment phase after spinal cord injury: A randomized, multicenter trial comparing low-dose heparin plus intermittent pneumatic compression with enoxaparin. J Trauma 2003;54:1116-1124; discussion 1125-1116.
81. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:381S-453S.
82. Aito S, Pieri A, D'Andrea M, Marcelli F, Cominelli E. Primary prevention of deep venous thrombosis and pulmonary embolism in acute spinal cord injured patients. Spinal Cord 2002;40:300-303.
83. Furlan JC, Fehlings MG. Role of screening tests for deep venous thrombosis in asymptomatic adults with acute spinal cord injury: An evidence-based analysis. Spine (Phila Pa 1976) 2007;32:1908-1916.
84. Powell M, Kirshblum S, O'Connor KC. Duplex ultrasound screening for deep vein thrombosis in spinal cord injured patients at rehabilitation admission. Arch Phys Med Rehabil 1999;80:1044-1046.
85. Gorman PH, Qadri SF, Rao-Patel A. Prophylactic inferior vena cava (IVC) filter placement may increase the relative risk of deep venous thrombosis after acute spinal cord injury. J Trauma 2009;66:707-712.
86. Becker DM, Philbrick JT, Selby JB. Inferior vena cava filters. Indications, safety, effectiveness. Arch Intern Med 1992;152:1985-1994.
87. Sing RF, Camp SM, Heniford BT, et al. Timing of pulmonary emboli after trauma: Implications for retrievable vena cava filters. J Trauma 2006;60:732-734; discussion 734-735.
88. Rogers FB. Venous thromboembolism in trauma patients: A review. Surgery 2001;130:1-12.
89. Shackford SR, Mackersie RC, Holbrook TL, et al. The epidemiology of traumatic death. A population-based analysis. Arch Surg 1993;128:571-575.
90. Knudson MM, Ikossi DG. Venous thromboembolism after trauma. Curr Opin Crit Care 2004;10:539-548.
91. Ginzburg E, Cohn SM, Lopez J, Jackowski J, Brown M, Hameed SM. Randomized clinical trial of intermittent pneumatic compression and low molecular weight heparin in trauma. Br J Surg 2003;90:1338-1344.
92. Stannard JP, Lopez-Ben RR, Volgas DA, et al. Prophylaxis against deep-vein thrombosis following trauma: A prospective, randomized comparison of mechanical and pharmacologic prophylaxis. J Bone Joint Surg Am 2006;88:261-266.
93. Fuchs S, Heyse T, Rudofsky G, Gosheger G, Chylarecki C. Continuous passive motion in the prevention of deep-vein thrombosis: A randomised comparison in trauma patients. J Bone Joint Surg Br 2005;87:1117-1122.
94. Meissner MH, Chandler WL, Elliott JS. Venous thromboembolism in trauma: A local manifestation of systemic hypercoagulability? J Trauma 2003;54:224-231.
95. Rogers FB, Cipolle MD, Velmahos G, Rozycki G, Luchette FA. Practice management guidelines for the prevention of venous thromboembolism in trauma patients: The EAST practice management guidelines work group. J Trauma 2002;53:142-164.
96. Borer DS, Starr AJ, Reinert CM, et al. The effect of screening for deep vein thrombosis on the prevalence of pulmonary embolism in patients with fractures of the pelvis or acetabulum: A review of 973 patients. J Orthop Trauma 2005;19:92-95.
97. Cipolle MD, Wojcik R, Seislove E, Wasser TE, Pasquale MD. The role of surveillance duplex scanning in preventing venous thromboembolism in trauma patients. J Trauma 2002;52:453-462.
98. Levine MN, Raskob G, Beyth RJ, Kearon C, Schulman S. Hemorrhagic complications of anticoagulant treatment: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):287S-310S.
99. Young T, Aukes J, Hughes R, Tang H. Vena caval filters for the prevention of pulmonary embolism. Cochrane Database Syst Rev 2007(3):CD006212.
100. Girard TD, Philbrick JT, Fritz Angle J, Becker DM. Prophylactic vena cava filters for trauma patients: A systematic review of the literature. Thromb Res 2003;112:261-267.
101. Spain DA, Richardson JD, Polk HC Jr., Bergamini TM, Wilson MA, Miller FB. Venous thromboembolism in the high-risk trauma patient: Do risks justify aggressive screening and prophylaxis? J Trauma 1997;42:463-467; discussion 467-469.
102. Joels CS, Sing RF, Heniford BT. Complications of inferior vena cava filters. Am Surg 2003;69:654-659.
103. Antevil JL, Sise MJ, Sack DI, et al. Retrievable vena cava filters for preventing pulmonary embolism in trauma patients: A cautionary tale. J Trauma 2006;60:35-40.
104. Cothren CC, Smith WR, Moore EE, Morgan SJ. Utility of once-daily dose of low-molecular-weight heparin to prevent venous thromboembolism in multisystem trauma patients. World J Surg 2007;31:98-104.
105. Given MF, McDonald BC, Brookfield P, et al. Retrievable Gunther Tulip inferior vena cava filter: Experience in 317 patients. J Med Imaging Radiat Oncol 2008;52:452-457.
106. Faucher LD, Conlon KM. Practice guidelines for deep venous thrombosis prophylaxis in burns. J Burn Care Res 2007;28:661-663.
107. Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):401S-428S.
108. Barret JP, Dziewulski PG. Complications of the hypercoagulable status in burn injury. Burns 2006;32:1005-1008.
109. Douketis JD, Gu C, Piccioli A, Ghirarduzzi A, Pengo V, Prandoni P. The long-term risk of cancer in patients with a first episode of venous thromboembolism. J Thromb Haemost 2009;7:546-551.
110. Arkel YS. Thrombosis and cancer. Semin Oncol 2000;27:362-374.
111. Descourt R, Le Gal G, Couturaud F, et al. Recurrent venous thromboembolism under anticoagulant therapy: A high risk in adenocarcinoma? Thromb Haemost 2006;95:912-913.
112. Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med 2000;343:1846-1850.
113. Chew HK, Wun T, Harvey D, Zhou H, White RH. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 2006;166:458-464.
114. Alcalay A, Wun T, Khatri V, et al. Venous thromboembolism in patients with colorectal cancer: Incidence and effect on survival. J Clin Oncol 2006;24:1112-1118.
115. Heit JA. Venous thromboembolism epidemiology: Implications for prevention and management. Semin Thromb Hemost 2002;28(Suppl 2):3-13.
116. Heit JA. Cancer and venous thromboembolism: Scope of the problem. Cancer Control 2005;12(Suppl 1):5-10.
117. Bergqvist D, Caprini JA, Dotsenko O, Kakkar AK, Mishra RG, Wakefield TW. Venous thromboembolism and cancer. Curr Probl Surg 2007;44:157-216.
118. Agnelli G, Bolis G, Capussotti L, et al. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: The @RISTOS project. Ann Surg 2006;243:89-95.
119. Bergqvist D, Agnelli G, Cohen AT, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002;346:975-980.
120. Rasmussen MS. Preventing thromboembolic complications in cancer patients after surgery: A role for prolonged thromboprophylaxis. Cancer Treat Rev 2002;28:141-144.
121. Gathof BS, Picker SM, Rojo J. Epidemiology, etiology and diagnosis of venous thrombosis. Eur J Med Res 2004;9:95-103.
122. Noble SI, Nelson A, Turner C, Finlay IG. Acceptability of low molecular weight heparin thromboprophylaxis for inpatients receiving palliative care: Qualitative study. BMJ 2006;332:577-580.
123. Wagman LD, Baird MF, Bennett CL, et al. Venous thromboembolic disease. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2006;4:838-869.
124. Lee AY, Levine MN, Baker RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003;349:146-153.
125. Martel N, Lee J, Wells PS. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: A meta-analysis. Blood 2005;106:2710-2715.
126. Linenberger ML. Catheter-related thrombosis: Risks, diagnosis, and management. J Natl Compr Canc Netw 2006;4:889-901.
127. Kovacs MJ, Kahn SR, Rodger M, et al. A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study). J Thromb Haemost 2007;5:1650-1653.
128. Nguyen NP, Borok TL, Welsh J, Vinh-Hung V. Safety and effectiveness of vascular endoprosthesis for malignant superior vena cava syndrome. Thorax 2009;64:174-178.
129. Prandoni P, Lensing AW, Piccioli A, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002;100:3484-3488.
130. Meyer G, Marjanovic Z, Valcke J, et al. Comparison of low-molecularweight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: A randomized controlled study. Arch Intern Med 2002;162:1729-1735.
131. Hull RD, Pineo GF, Brant RF, et al. Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer. Am J Med 2006;119:1062-1072.
132. Schiff RL, Kahn SR, Shrier I, et al. Identifying orthopedic patients at high risk for venous thromboembolism despite thromboprophylaxis. Chest 2005;128:3364-3371.
133. Hoppener MR, Ettema HB, Henny CP, Verheyen CC, Buller HR. Low incidence of deep vein thrombosis after knee arthroscopy without thromboprophylaxis: A prospective cohort study of 335 patients. Acta Orthop 2006;77:767-771.
134. Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL. Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty. Anesthesiology 2003;99:552-560; discussion 555A.
135. Nathan SS, Simmons KA, Lin PP, et al. Proximal deep vein thrombosis after hip replacement for oncologic indications. J Bone Joint Surg Am 2006;88:1066-1070.
136. Lassen MR, Bauer KA, Eriksson BI, Turpie AG. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: A randomised double-blind comparison. Lancet 2002;359:1715-1720.
137. Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: A randomised double-blind trial. Lancet 2002;359:1721-1726.
138. Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: A meta-analysis of 4 randomized double-blind studies. Arch Intern Med 2002;162:1833-1840.
139. Eriksson BI, Bauer KA, Lassen MR, Turpie AG. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med 2001;345:1298-1304.
140. Glotzbecker MP, Bono CM, Wood KB, Harris MB. Thromboembolic disease in spinal surgery: A systematic review. Spine (Phila Pa 1976) 2009;34:291-303.
141. Huang ME, Johns JS, White J, Sanford K. Venous thromboembolism in a rehabilitation setting after major lower-extremity amputation. Arch Phys Med Rehabil 2005;86:73-78.
142. Zickler RW, Gahtan V, Matsumoto T, Kerstein MD. Deep venous thrombosis and pulmonary embolism in bilateral lower-extremity amputee patients. Arch Phys Med Rehabil 1999;80:509-511.
143. Chong DK, Panju A. Deep venous thrombosis as a cause of stump swelling in two lower extremity amputee patients. Arch Phys Med Rehabil 1993;74:1002-1003.
144. Knight MT, Dawson R. Effect of intermittent compression of the arms on deep venous thrombosis in the legs. Lancet 1976;2:1265-1268.
145. Killewich LA, Cahan MA, Hanna DJ, et al. The effect of external pneumatic compression on regional fibrinolysis in a prospective randomized trial. J Vasc Surg 2002;36:953-958.
146. Cahan MA, Hanna DJ, Wiley LA, Cox DK, Killewich LA. External pneumatic compression and fibrinolysis in abdominal surgery. J Vasc Surg 2000;32:537-543.
147. Brandstater ME, Roth EJ, Siebens HC. Venous thromboembolism in stroke: Literature review and implications for clinical practice. Arch Phys Med Rehabil 992;73:S379 -S391.
148. Skaf E, Stein PD, Beemath A, Sanchez J, Bustamante MA, Olson RE. Venous thromboembolism in patients with ischemic and hemorrhagic stroke. Am J Cardiol 2005;96:1731-1733.
149. Kamran SI, Downey D, Ruff RL. Pneumatic sequential compression reduces the risk of deep vein thrombosis in stroke patients. Neurology 1998;50:1683-1688.
150. Imberti D, Prisco D. Venous thromboembolism prophylaxis in medical patients: Future perspectives. Thromb Res 2005;116:365-375.
151. Davenport RJ, Dennis MS, Wellwood I, Warlow CP. Complications after acute stroke. Stroke 1996;27:415-420.
152. Aptaker RL, Roth EJ, Reichhardt G, Duerden ME, Levy CE. Serum albumin level as a predictor of geriatric stroke rehabilitation outcome. Arch Phys Med Rehabil 1994;75:80-84.
153. Kelly J, Rudd A, Lewis R, Hunt BJ. Venous thromboembolism after acute stroke. Stroke 2001;32:262-267.
154. Sandercock P, Counsell C, Stobbs SL. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke. Cochrane Database Syst Rev 2005;(2):CD000119.
155. Harvey RL, Lovell LL, Belanger N, Roth EJ. The effectiveness of anticoagulant and antiplatelet agents in preventing venous thromboembolism during stroke rehabilitation: A historical cohort study. Arch Phys Med Rehabil 2004;85:1070-1075.
156. Gubitz G, Sandercock P, Counsell C. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev 2004;(3):CD00002.
157. Chamorro A, Vila N, Saiz A, Alday M, Tolosa E. Early anticoagulation after large cerebral embolic infarction: A safety study. Neurology 1995;45:861-865.
158. Gregory PC, Kuhlemeier KV. Prevalence of venous thromboembolism in acute hemorrhagic and thromboembolic stroke. Am J Phys Med Rehabil 2003;82:364-369.
159. Mazzone C, Chiodo Grandi F, Sandercock P, Miccio M, Salvi R. Physical methods for preventing deep vein thrombosis in stroke. Cochrane Database Syst Rev 2004;(4):CD001922
160. Kamphuisen PW, Agnelli G. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke? Thromb Res 2007;119:265-274.
161. Kearon CM, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:454S-545S.
162. Bath PM, Iddenden R, Bath FJ. Low-molecular-weight heparins and heparinoids in acute ischemic stroke: A meta-analysis of randomized controlled trials. Stroke 2000;31:1770-1778.
163. Kamphuisen PW, Agnelli G, Sebastianelli M. Prevention of venous thromboembolism after acute ischemic stroke. J Thromb Haemost 2005;3:1187-1194.
164. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: A guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation 2007;116:e391-413.
165. Iorio A, Agnelli G. Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: A metaanalysis. Arch Intern Med 2000;160:2327-2332.
166. Schulman S, Beyth RJ, Kearon C, Levine MN. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:257S-298S.
167. Wilson RD, Murray PK. Cost-effectiveness of screening for deep vein thrombosis by ultrasound at admission to stroke rehabilitation. Arch Phys Med Rehabil 2005;86:1941-1948.
168. Reiff DA, Haricharan RN, Bullington NM, Griffin RL, McGwin G Jr, Rue LW 3rd. Traumatic brain injury is associated with the development of deep vein thrombosis independent of pharmacological prophylaxis. J Trauma 2009;66:1436-1440.
169. Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med 1994;331:1601-1606.
170. Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. V. Deep vein thrombosis prophylaxis. J Neurotrauma 2007;24(Suppl 1):S32-S36.
171. Yablon SA, Rock WA, Ng WK, Nick TG, McGrath CM. Evidence for an acute-phase hypercoagulable state as a major risk factor for venous thromboembolic disease among rehabilitation admission with acquired brain injury. Am J Phys Med Rehabil 2000;79:204-205.
172. Carlile MC, Yablon SA, Mysiw WJ, Frol AB, Lo D, Diaz-Arrastia R. Deep venous thrombosis management following traumatic brain injury: A practice survey of the traumatic brain injury model systems. J Head Trauma Rehabil 2006;21:483-490.
173. Hyers TM, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease. Chest 2001;119(1 Suppl):176S- 193S.
174. Kim J, Gearhart MM, Zurick A, Zuccarello M, James L, Luchette FA. Preliminary report on the safety of heparin for deep venous thrombosis prophylaxis after severe head injury. J Trauma 2002;53:38-42; discussion 43.
175. Meythaler JM, Fisher WS, Rue LW, Johnson A, Davis L, Brunner RC. Screening for venous thromboembolism in traumatic brain injury: Limitations of D-dimer assay. Arch Phys Med Rehabil 2003;84:285-290.
176. Yablon SA, Rock WA Jr, Nick TG, Sherer M, McGrath CM, Goodson KH. Deep vein thrombosis: Prevalence and risk factors in rehabilitation admissions with brain injury. Neurology 2004;63:485-491.
177. Prisco D, Grifoni E. The role of D-dimer testing in patients with suspected venous thromboembolism. Semin Thromb Hemost 2009;35:50-59.
178. Cifu DX, Kaelin DL, Wall BE. Deep venous thrombosis: Incidence on admission to a brain injury rehabilitation program. Arch Phys Med Rehabil 1996;77:1182-1185.
179. Meythaler JM, DeVivo MJ, Hayne JB. Cost-effectiveness of routine screening for proximal deep venous thrombosis in acquired brain injury patients admitted to rehabilitation. Arch Phys Med Rehabil 1996;77:1-5.
180. Page RB, Spott MA, Krishnamurthy S, Taleghani C, Chinchilli VM. Head injury and pulmonary embolism: A retrospective report based on the Pennsylvania Trauma Outcomes study. Neurosurgery 2004;54:143-148; discussion 148-149.
181. Marras LC, Geerts WH, Perry JR. The risk of venous thromboembolism is increased throughout the course of malignant glioma: An evidence-based review. Cancer 2000;89:640-646.
182. Chan AT, Atiemo A, Diran LK, et al. Venous thromboembolism occurs frequently in patients undergoing brain tumor surgery despite prophylaxis. J Thromb Thrombolysis 1999;8:139-142.
183. Walsh DC, Kakkar AK. Thromboembolism in brain tumors. Curr Opin Pulm Med 2001;7:326-331.
184. Ruff RL, Posner JB. Incidence and treatment of peripheral venous thrombosis in patients with glioma. Ann Neurol 1983;13:334-336.
185. Wen DY, Hall WA. Complications of subcutaneous low-dose heparin therapy in neurosurgical patients. Surg Neurol 1998;50:521-525.
186. Macdonald RL, Amidei C, Lin G, et al. Safety of perioperative subcutaneous heparin for prophylaxis of venous thromboembolism in patients undergoing craniotomy. Neurosurgery 1999;45:245-251; discussion 251-242.
187. Constantini S, Kanner A, Friedman A, et al. Safety of perioperative minidose heparin in patients undergoing brain tumor surgery: A prospective, randomized, double-blind study. J Neurosurg 2001;94:918-921.
188. Agnelli G, Piovella F, Buoncristiani P, et al. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med 1998;339:80-85.
189. Dickinson LD, Miller LD, Patel CP, Gupta SK. Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery 1998;43:1074-1081.
190. Cage TA, Lamborn KR, Ware ML, et al. Adjuvant enoxaparin therapy may decrease the incidence of postoperative thrombotic events though does not increase the incidence of postoperative intracranial hemorrhage in patients with meningiomas. J Neurooncol 2009;93:151-156.
191. Tetri S, Hakala J, Juvela S, et al. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage. Thromb Res 2008;123:206-212.
192. Raabe A, Gerlach R, Zimmermann M, Seifert V. The risk of haemorrhage associated with early postoperative heparin administration after intracranial surgery. Acta Neurochir (Wien) 2001;143:1-7.
193. Goldhaber SZ, Dunn K, Gerhard-Herman M, Park JK, Black PM. Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis. Chest 2002;122:1933-1937.
194. Sharpe RP, Gupta R, Gracias VH, et al. Incidence and natural history of below-knee deep venous thrombosis in high-risk trauma patients. J Trauma 2002;53:1048-1052.
195. Kiser TS, Stefans VA. Pulmonary embolism in rehabilitation patients: Relation to time before return to physical therapy after diagnosis of deep vein thrombosis. Arch Phys Med Rehabil 1997;78:942-945.
196. Kahn SR, Shrier I, Kearon C. Physical activity in patients with deep venous thrombosis: A systematic review. Thromb Res 2008;122:763-773.
197. Aldrich D, Hunt DP. When can the patient with deep venous thrombosis begin to ambulate? Phys Ther 2004;84:268-273.
198. Ciccone CD. Clinical question: Does ambulation immediately following an episode of deep vein thrombosis increase the risk of pulmonary embolism? Phys Ther 2002;82:84-88.
199. Aschwanden M, Labs KH, Engel H, et al. Acute deep vein thrombosis: Early mobilization does not increase the frequency of pulmonary embolism. Thromb Haemost 2001;85:42-46.
200. Partsch H. Ambulation and compression after deep vein thrombosis: Dispelling myths. Semin Vasc Surg 2005;18:148-152.
201. Partsch H, Blattler W. Compression and walking versus bed rest in the treatment of proximal deep venous thrombosis with low molecular weight heparin. J Vasc Surg 2000;32:861-869.
202. Kroll HR, Odderson IR, Allen FH. Deep vein thrombi associated with the use of plastic ankle-foot orthoses. Arch Phys Med Rehabil 1998;79:576-578.
203. Hara Y. Deep venous thrombosis in stroke patients during rehabilitation phase. Keio J Med 2008;57:196-204.
204. Segal JB, Streiff MB, Hofmann LV, Thornton K, Bass EB. Management of venous thromboembolism: A systematic review for a practice guideline. Ann Intern Med 2007;146:211-222.
205. Linkins LA, Choi PT, Douketis JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: A meta-analysis. Ann Intern Med 2003;139:893-900.
206. van Dongen CJ, Vink R, Hutten BA, Buller HR, Prins MH. The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: A metaanalysis. Arch Intern Med 2003;163:1285-1293.
207. Agnelli G, Prandoni P, Santamaria MG, et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. N Engl J Med 2001;345:165-169.
208. Palareti G, Cosmi B, Legnani C, et al. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med 2006;355:1780-1789.
209. Cosmi B, Legnani C, Cini M, Guazzaloca G, Palareti G. D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis. Thromb Haemost 2005;94:969-974.
210. Ridker PM, Goldhaber SZ, Danielson E, et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med 2003;348:1425-1434.
211. Kearon C, Ginsberg JS, Kovacs MJ, et al. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 2003;349:631-639.